Literature DB >> 22379685

International Conference on Harmonisation; Guidance on E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers; availability. Notice.

.   

Abstract

The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled ``E7 Studies in Support of Special Populations: Geriatrics; Questions and Answers.'' The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The questions and answers (Q&A) guidance addresses special considerations for the design and conduct of clinical trials of drugs likely to have significant use in the elderly. The Q&As are intended to provide guidance on the use of geriatric data to adequately characterize and represent the safety and efficacy of a drug for a marketing application, including data collected postmarketing.

Entities:  

Mesh:

Year:  2012        PMID: 22379685

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  6 in total

1.  Regulatory activities to address the needs of older patients.

Authors:  F Cerreta; R Temple; Y Asahina; C Connaire
Journal:  J Nutr Health Aging       Date:  2015-02       Impact factor: 4.075

Review 2.  Position paper on an ageing society.

Authors:  András Süle; Nenad Miljković; Piera Polidori; Stephanie Kohl
Journal:  Eur J Hosp Pharm       Date:  2019-07-24

3.  Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015.

Authors:  Alice Chen; Hilary Wright; Hawi Itana; Merina Elahi; Ayomide Igun; Guoxing Soon; Anne R Pariser; Emmanuel O Fadiran
Journal:  J Womens Health (Larchmt)       Date:  2017-10-19       Impact factor: 2.681

4.  Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.

Authors:  Johann S de Bono; Matthew R Smith; Fred Saad; Dana E Rathkopf; Peter F A Mulders; Eric J Small; Neal D Shore; Karim Fizazi; Peter De Porre; Thian Kheoh; Jinhui Li; Mary B Todd; Charles J Ryan; Thomas W Flaig
Journal:  Eur Urol       Date:  2016-07-09       Impact factor: 20.096

5.  Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.

Authors:  Saur Hajiev; Elias Allara; Leila Motedayеn Aval; Tadaaki Arizumi; Dominik Bettinger; Mario Pirisi; Lorenza Rimassa; Tiziana Pressiani; Nicola Personeni; Laura Giordano; Masatoshi Kudo; Robert Thimme; Joong-Won Park; Tamar H Taddei; David E Kaplan; Ramya Ramaswami; David J Pinato; Rohini Sharma
Journal:  Br J Cancer       Date:  2020-10-19       Impact factor: 7.640

6.  Under-representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database.

Authors:  Rikje Ruiter; Jacobus Burggraaf; Robert Rissmann
Journal:  Br J Clin Pharmacol       Date:  2019-02-23       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.